drugset / Trial / NCT03039699

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children

NCT03039699

Phase 4 Completed 259 enrolled Materia Medica Holding
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to obtain additional data on efficacy and safety of Ergoferon in the treatment of viral intestinal infections in inpatient children.

Timeline

Start
2016-06-23
Primary completion
2019-06-01
Completion
2019-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergoferon Protein / enzyme biologic 1 unknown Oral